Steven Waggoner, MD, is Division Chief, Gynecologic Oncology, at UH Seidman Cancer Center, and Professor, Obstetrics and Gynecology, at Case Western Reserve University School of Medicine.
Dr. Waggoner is board certified in obstetrics and gynecology as well as gynecologic oncology. His special interests include gynecologic oncology, cervical dysplasia, minimally invasive / endoscopic surgery, oncofertility, hospice and palliative medicine, and complementary and integrative medicine. He joined the UH Cleveland Medical Center staff in 2002.
Dr. Waggoner completed his undergraduate work at University of Puget Sound and earned his medical degree from University of Washington in Seattle. He served a residency in obstetrics and gynecology at University of Chicago and a fellowship in gynecologic oncology at Georgetown University.
A renowned researcher, Dr. Waggoner has received numerous grants for research studies related to cervical, endometrial and ovarian cancers.
He has published more than 100 papers and editorials about his basic and clinical research in peer-reviewed journals and has authored 15 textbook chapters. Dr. Waggoner also has made abstract presentations at national medical meetings and been an invited speaker at numerous national, regional and international meetings.
Dr. Waggoner is a member of the NRG Oncology Ancillary Protocol Committee and Membership Committee. He serves as a Principal Investigator for NRG Oncology and GOG Foundation activities at University Hospitals Cleveland Medical Center.
American Board of Obstetrics and Gynecology - Gynecologic Oncology
American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Education & Training
1980, University of Puget Sound
Medical / Professional School(s)
1984, University of Washington
1985, Obstetrics and Gynecology - University of Chicago Medical Center
1988, Obstetrics and Gynecology - University of Chicago Medical Center
1991, Gynecologic Oncology - Georgetown University Hospital
Cervical Dysplasia, Gynecological Oncology, Obstetrics and Gynecology, Ovarian Cancer, Quality of Life
Awards & Recognition
- President’s Award, 21st Annual Meeting, Society of Gynecologic Oncologists, 1990
- President’s Award, 22nd Annual Meeting, Society of Gynecologic Oncologists, 1991
- American Cancer Society Clinical Oncology Career Development Award, 1992-1995
- Castle Connolly “America’s Top Doctor” Citation, 2003-14
- Castle Connolly “America’s Top Doctors for Cancer” Citation Oncologists, 2005-14
UH Cleveland Medical Center
Department of OB/GYN-Gynecological Oncology
11100 Euclid Ave
UH Mentor Health Center
9000 Mentor Ave
UH Chagrin Highlands Health Center
3909 Orange Pl
UH Sharon Health Center
5133 Ridge Rd
Seidman Cancer Center, Ste 5
Gynecologic malignancies, Cervical dysplasia, Obesity and endometrial cancer
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Steven Waggoner, MD did not disclose any Outside Relationships with Industry.